visilizumab

A monoclonal antibody that binds to CD3 (a substance found on T-cells) and that is being studied as a treatment for graft-versus-host disease (GVHD). It belongs to the family of drugs called monoclonal antibodies.


Selected visilizumab links:

© 2004 TheHealthEncyclopedia.com.   If you have comments or additions that you wish to make, please email us.  If you found this site useful, feel free to tell others or link to it from your site!  TheHealthEncyclopedia.com is a purely informational website, and should not be used as a substitute for professional legal, medical or technical advice.